Search Results

You are looking at 1 - 2 of 2 items for :

  • MAPK signaling x
  • Endocrine Society of Australia special collection x
  • Refine by access: All content x
Clear All
Adam Hagg School of Biomedical Sciences, University of Queensland, Brisbane, Australia

Search for other papers by Adam Hagg in
Google Scholar
PubMed
Close
,
Eliza O’Shea School of Biomedical Sciences, University of Queensland, Brisbane, Australia

Search for other papers by Eliza O’Shea in
Google Scholar
PubMed
Close
,
Craig A Harrison Department of Physiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia

Search for other papers by Craig A Harrison in
Google Scholar
PubMed
Close
, and
Kelly L Walton School of Biomedical Sciences, University of Queensland, Brisbane, Australia
Department of Physiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia

Search for other papers by Kelly L Walton in
Google Scholar
PubMed
Close

complex with the ActRIIA/B receptors which effectively disables intracellular SMAD activation ( Fig. 2A ). Activin A and activin B have also been reported to stimulate SMAD-independent signalling pathways involving p38 MAPK, ERK1/2 and JNK ( Bao et al

Free access
Sunita M C De Sousa Endocrine & Metabolic Unit, Royal Adelaide Hospital, Adelaide, Australia
South Australian Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, Australia
Adelaide Medical School, University of Adelaide, Adelaide, Australia

Search for other papers by Sunita M C De Sousa in
Google Scholar
PubMed
Close
,
Nèle F Lenders Department of Endocrinology, St Vincent’s Hospital, Sydney, NSW, Australia
Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia

Search for other papers by Nèle F Lenders in
Google Scholar
PubMed
Close
,
Lydia S Lamb Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia

Search for other papers by Lydia S Lamb in
Google Scholar
PubMed
Close
,
Warrick J Inder Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, Australia
Academy for Medical Education, Faculty of Medicine, the University of Queensland, Brisbane, Australia

Search for other papers by Warrick J Inder in
Google Scholar
PubMed
Close
, and
Ann McCormack Department of Endocrinology, St Vincent’s Hospital, Sydney, NSW, Australia
Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia

Search for other papers by Ann McCormack in
Google Scholar
PubMed
Close

. 2020 b ). EGFR is a transmembrane glycoprotein, the binding of which triggers downstream signalling via MAPK and P13K pathways. Increased EGFR expression has been associated with proliferation, angiogenesis, invasion, recurrence and transition of PAs

Free access